Results 51 to 60 of about 825,494 (348)

"Person in the barrel" syndrome: Unusual heralding presentation of squamous cell carcinoma of the lung

Annals of Indian Academy of Neurology, 2016
Paraneoplastic neurological syndromes (PNS) are rare and relatively unusual in day to day clinical practice. Occasionally, PNS may be the heralding manifestation of the malignancy.
Rajesh Verma, Rakesh Lalla, Tushar B Patil, Suresh Babu   +3 more
doaj   +1 more source

Genetic variant of miR-4293 rs12220909 is associated with susceptibility to non-small cell lung cancer in a Chinese Han population. [PDF]

PLoS ONE, 2017
Non-small cell lung cancer is one of the most common cancers and the leading cause of cancer death worldwide. Genetic variants in regulatory regions of some miRNAs might be involved in non-small cell lung cancer susceptibility and survival. rs12220909 (G/
Lixia Fan, Linqi Chen, Xiaoling Ni, Shicheng Guo, Yinghui Zhou, Chenji Wang, Yabiao Zheng, Fangyuan Shen, Vijay Kumar Kolluri, Merlin Muktiali, Zhenhong Zhao, Junjie Wu, Dunmei Zhao, Zhenglei He, Xulong Feng, Ziyu Yuan, Juan Zhang, Li Jin, Jiucun Wang, Minghua Wang   +19 more
doaj   +1 more source

Preferential Localization of MUC1 Glycoprotein in Exosomes Secreted by Non-Small Cell Lung Carcinoma Cells

International Journal of Molecular Sciences, 2019
Lung cancer remains to be the leading cause of cancer-related mortality worldwide. Finding new noninvasive biomarkers for lung cancer is still a significant clinical challenge. Exosomes are membrane-bound, nano-sized vesicles that are released by various
Deng Pan, Jiaxi Chen, C. Feng, Weibo Wu, Yanjin Wang, Jiao Tong, Dapeng Zhou   +6 more
semanticscholar   +1 more source

Histological transformation of adenocarcinoma to small cell carcinoma lung as a rare mechanism of resistance to epidermal growth factor receptor-tyrosine kinase inhibitors: Report of a case with review of literature

Lung India, 2018
A subset of non-small cell lung carcinoma (NSCC) harbor active mutations of epidermal growth factor receptor (EGFR). In these, EGFR tyrosine kinase inhibitors (EGFR-TKIs) are recommended as the first-line treatment.
Monalisa Hui, Shantveer G Uppin, Bala Joseph Stalin, G Sadashivudu   +3 more
doaj   +1 more source

Study of PD-L1 Expression in Tumours Based on Site and Histology of Tumour – The Experience of a Tertiary Referral Laboratory

Asian Pacific Journal of Cancer Biology, 2023
Background: PD-L1 IHC test is used as a predictive biomarker using FDA-approved assays to select patients likely to benefit from immunotherapy in several advanced-stage tumors. We aim to present our data regarding the prevalence and expression pattern of
Vinita Pant, Munmun Harlalka
doaj   +1 more source

The Gut Microbiome Associates with Immune Checkpoint Inhibition Outcomes in Patients with Advanced Non–Small Cell Lung Cancer

Cancer immunology research, 2020
The gut microbiome influences the efficacy of immune checkpoint inhibition (ICI). In non–small cell lung carcinoma patients, antibiotics have a negative impact on ICI efficacy, correlating to enrichment of Ruminococcaceae UCG 13 and Agathobacter in the ...
T. Hakozaki, C. Richard, A. Elkrief, Y. Hosomi, M. Benlaïfaoui, Iris L Mimpen, S. Terrisse, L. Derosa, L. Zitvogel, B. Routy, Y. Okuma   +10 more
semanticscholar   +1 more source

Clinical and Pathological Characteristics of KEAP1- and NFE2L2-Mutated Non–Small Cell Lung Carcinoma (NSCLC)

Clinical Cancer Research, 2018
Purpose: KEAP1 and NFE2L2 mutations are associated with impaired prognosis in a variety of cancers and with squamous cell carcinoma formation in non–small cell lung cancer (NSCLC). However, little is known about frequency, histology dependence, molecular
R. Frank, M. Scheffler, S. Merkelbach-Bruse, M. Ihle, A. Kron, Michael Rauer, F. Ueckeroth, K. König, S. Michels, R. Fischer, A. Eisert, J. Fassunke, C. Heydt, M. Serke, Y. Ko, U. Gerigk, T. Geist, B. Kaminsky, L. Heukamp, M. Clément-Ziza, R. Büttner, J. Wolf   +21 more
semanticscholar   +1 more source

The Diagnostic Accuracy of Chest CT in the Detection of Tumor and Nodal Status in Non Small Cell Lung Carcinoma [PDF]

, 2003
At this time there is an increasing demand for an accurate pre operative staging in non small cell lung cancer. Chest Computed Tomography (CT) is one of the imaging modality of choice used for this purpose.
Busroh, I. (Ismid), Icksan, A. (Aziza), Syachruddin, E. (Elisna), Yusuf, A. (Anwar)   +3 more
core   +1 more source

Transdifferentiation of lung adenocarcinoma in mice with Lkb1 deficiency to squamous cell carcinoma [PDF]

, 2014
Lineage transition in adenocarcinoma (ADC) and squamous cell carcinoma (SCC) of non-small cell lung cancer, as implicated by clinical observation of mixed ADC and SCC pathologies in adenosquamous cell carcinoma, remains a fundamental yet unsolved ...
Chen, Haiquan, Fang, Jing, Fang, Rong, Fang, Zhaoyuan, Gao, Yijun, Ge, Gaoxiang, Han, Xiangkun, Hou, Yingyong, Ji, Hongbin, Li, Fei, Li, Fuming, Li, Li, Ma, Huimin, Sun, Yihua, Wang, Hongda, Wong, Kwok-kin, Xiao, Qian, Yao, Shun, Zhang, Lei, Zhang, Wenjing   +19 more
core   +1 more source

Psychosocial Outcomes in Patients With Endocrine Tumor Syndromes: A Systematic Review

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Introduction The combination of disease manifestations, the familial burden, and varying penetrance of endocrine tumor syndromes (ETSs) is unique. This review aimed to portray and summarize available data on psychosocial outcomes in patients with ETSs and explore gaps and opportunities for future research and care.
Daniël Zwerus, Floortje Strobbe, Annemarie A. Verrijn Stuart, Hanneke M. van Santen, Gerlof D. Valk, Sasja A. Schepers, Rachel S. van Leeuwaarde   +6 more
wiley   +1 more source